Diabetes News and Research

Latest Diabetes News and Research

Study finds link between fasting serum glucose levels and in-hospital mortality in elderly non-diabetic patients

A two-country hospital study of 808 elderly patients found a strong association between high, undiagnosed blood glucose in non-diabetic patients and increased hospital death rates, according to the March issue of IJCP, the International Journal of Clinical Practice.

24 Feb 2011

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.

24 Feb 2011

Roche receives DOD approval to provide remote service and support for its lab analyzers

Roche announced today that it has received approval from the U.S. Department of Defense to provide remote service and support for its lab analyzers at Womack Army Medical Center through the DOD's secure B2B gateway. Roche is the first in-vitro diagnostics manufacturer to be approved by the DOD for this remote access.

From Roche Sequencing and Life Science 24 Feb 2011

UK HealthCare to deploy Allscripts EHR, Practice Management solution for faculty providers

UK HealthCare, the patient care operations of University of Kentucky, will deploy the Allscripts lectronic Health Record and Practice Management solution to help its team of 6,000 physicians, nurses, pharmacists and health care providers enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.

24 Feb 2011

Stamford Hospital to participate in US FDA Expanded Access Treatment IND program for Generex Oral-lyn

Generex Biotechnology Corporation announced today that Stamford Hospital has agreed to participate in the United States Food and Drug Administration Expanded Access Treatment Investigational New Drug Program for Generex Oral-lyn, the Company's proprietary buccal insulin spray product for the treatment of patients with diabetes.

24 Feb 2011

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.

24 Feb 2011

BRI and Eureka Genomics form strategic alliance to advance cancer treatments

Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and bioinformatics pioneer Eureka Genomics (EG) have formed a strategic alliance to achieve a better understanding of the causes of colorectal cancer, potentially leading to advancements in the disease's prevention, management and treatment.

24 Feb 2011

Excess weight contributes to higher risk of death in Asians

A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.

24 Feb 2011

Researchers study mobile health technology options to help patients manage diabetes

The McKesson Foundation today announced the six recipients of $1.3 million in research grants as part of its Mobilizing for Healthsm initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology.

24 Feb 2011

ProtoKinetix demonstrates ability of AAGP molecules against inflammatory diseases

ProtoKinetix (OTCBB: PKTX) (www.protokinetix.com ), a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine, biotechnology and cosmetic industries stated that it has repeatedly demonstrated the ability of their AAGP™ molecule to protect against the attacks of the most hostile inflammation causing agents known.

24 Feb 2011

Progeria-derived iPS cells may treat aging-related disease in children

The current pace of population aging is without parallel in human history but surprisingly little is known about the human aging process, because lifespans of eight decades or more make it difficult to study. Now, researchers at the Salk Institute for Biological Studies have replicated premature aging in the lab, allowing them to study aging-related disease in a dish.

24 Feb 2011

Scientists find bovine colostrum can massively reduce leaky gut syndrome

Scientists investigating natural ways to enhance athletic performance have found that bovine colostrum can massively reduce gut permeability - otherwise known as 'leaky gut syndrome.'

24 Feb 2011

FDA approves ONGLYZA to treat type 2 diabetes patients with renal impairment

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has approved the inclusion of data from two clinical studies in an update to the ONGLYZA U.S. Prescribing Information for adult type 2 diabetes patients.

24 Feb 2011

Novo Nordisk submits rFXIII BLA to FDA for treatment of inherited bleeding disorder

Novo Nordisk announced today that a Biologic License Application has been submitted to the U.S. Food and Drug Administration requesting the approval of a recombinant factor XIII compound for the vast majority of patients with congenital factor XIII deficiency, an inherited bleeding disorder.

From Novo Nordisk 23 Feb 2011

Australia’s top scientist takes on top job

Today, the man who is known for one of Australia’s greatest medical achievements – the development of a cervical cancer vaccine – has been appointed as Chief Executive Officer of the Translational Research Institute (TRI) in Brisbane, Queensland.

23 Feb 2011

Diabetes technology granted patent in Australia

Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) a global company pioneering the development of a cell implant therapy to treat diabetes and neurodegenerative diseases, has been granted a patent by the Australian Patent Office for IMMUPEL(tm), LCT's industry-leading technology for encapsulating living cells prior to transplantation.

23 Feb 2011

MEDSEEK chosen by Trinity Health to implement online patient experience

MEDSEEK, a provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced plans to deepen its relationship with long-time partner Trinity Health. It will develop, design and implement the healthcare system’s fully integrated online patient experience.

23 Feb 2011

Diabetes News and Research

Latest Diabetes News and Research

Study finds link between fasting serum glucose levels and in-hospital mortality in elderly non-diabetic patients

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Roche receives DOD approval to provide remote service and support for its lab analyzers

UK HealthCare to deploy Allscripts EHR, Practice Management solution for faculty providers

Stamford Hospital to participate in US FDA Expanded Access Treatment IND program for Generex Oral-lyn

Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension

BRI and Eureka Genomics form strategic alliance to advance cancer treatments

Excess weight contributes to higher risk of death in Asians

Researchers study mobile health technology options to help patients manage diabetes

ProtoKinetix demonstrates ability of AAGP molecules against inflammatory diseases

Progeria-derived iPS cells may treat aging-related disease in children

Scientists find bovine colostrum can massively reduce leaky gut syndrome

FDA approves ONGLYZA to treat type 2 diabetes patients with renal impairment

Novo Nordisk submits rFXIII BLA to FDA for treatment of inherited bleeding disorder

Australia’s top scientist takes on top job

Diabetes technology granted patent in Australia

MEDSEEK chosen by Trinity Health to implement online patient experience

Tips for heart healthiness

Nanoparticle therapy may improve survival after life-threatening blood loss

Study: Hemoglobin A1c is not a reliable test to diagnose diabetes in children

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Diabetes News and Research

Latest Diabetes News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in